Target intelligence / Profile preview

Helicase-primase complex of herpesviruses (None universally adopted; sometimes referred to as HSV-1 UL5/UL8/UL52 complex or HCMV pUL105-pUL102-pUL70 complex, depending on viral species)

Target
None universally adopted; sometimes referred to as HSV-1 UL5/UL8/UL52 complex or HCMV pUL105-pUL102-pUL70 complex, depending on viral species
Molecular classification
Enzyme complex, DNA helicase (UL5 or pUL105), DNA primase (UL52 or pUL70), Polymerase cofactor/non-catalytic subunit (UL8 or pUL102; structurally related to B-family polymerases, but catalytically inactive)
01

Overview

The helicase-primase complex of herpesviruses is a multifunctional enzyme complex required for viral DNA replication. In herpes simplex virus-1 (HSV-1), it consists of three proteins: UL5 (helicase), UL52 (primase), and UL8 (non-catalytic cofactor). Each component is essential for coordinated unwinding of DNA and the synthesis of RNA primers on the lagging strand, enabling viral genome propagation in infected host cells. The structure and function of this complex are conserved in other herpesviruses such as human cytomegalovirus (HCMV), where the analogous proteins are pUL105 (helicase), pUL70 (primase), and pUL102 (cofactor). The complex is the target of novel antiviral drugs (e.g., amenamevir, pritelivir) that inhibit its enzymatic activities, resulting in blockage of viral replication. Drug resistance arises through mutations in the functional domains of UL5 and UL52. The non-catalytic subunit UL8 is structurally related to the B-family of DNA polymerases but is catalytically inactive, serving a scaffold role. Therapeutic targeting of this complex is a strategy especially relevant in cases where standard polymerase inhibitors fail due to resistance.

Other names
UL5/UL8/UL52 complex (for HSV-1)pUL105-pUL102-pUL70 complex (for HCMV)Helicase–primase complex
02

Mechanism of action

Direct inhibition of helicase ATPase and primase activities, which disables viral DNA replication and replication fork progression. Binding of inhibitors to key motifs within the helicase/primase complex, notably within UL5 and UL52 subunits interfering with ATP binding, unwinding, and primer synthesis.

03

Biological functions

Viral DNA replication initiationDNA unwinding (helicase activity)RNA primer synthesis (primase activity)Coordination of leading and lagging strand DNA synthesisFacilitates viral genome replication and proliferation
04

Disease associations

Infection (causative protein complex in herpesvirus diseases: HSV, VZV, HCMV, etc.)
05

Safety considerations

Potential for rapid selection of drug-resistant viral strains under antiviral pressureMany inhibitors are still under investigation, so long-term toxicity and off-target effects in humans are not fully definedOverall class shares typical adverse profile of anti-herpes antivirals
06

Interacting drugs

Amenamevir (ASP2151)

3 more in the full profile.

07

Biomarkers

Mutations in UL5 and UL52 associated with resistance to helicase-primase inhibitors (e.g., G352, M355T, K356N in UL5; Y222C in UL52 for HSV-1)No broadly used patient selection biomarkers; resistance mutation monitoring may be applied for therapeutic efficacy

Beyond the preview

Go deeper on Helicase-primase complex of herpesviruses (None universally adopted; sometimes referred to as HSV-1 UL5/UL8/UL52 complex or HCMV pUL105-pUL102-pUL70 complex, depending on viral species).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Helicase-primase complex of herpesviruses (None universally adopted; sometimes referred to as HSV-1 UL5/UL8/UL52 complex or HCMV pUL105-pUL102-pUL70 complex, depending on viral species).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call